510(k) device
Eko Low Ejection Fraction Tool (ELEFT)
Eko Health, Inc. · Reduced Ejection Fraction Machine Learning-Based Notification Software (QYE, Class II) · First FDA decision Mar 28, 2024, newest Mar 28, 2024Heart failure
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
Breakthrough-designated
Device trials
5
Naming "Eko Low"
MAUDE reports
0
Brand "Eko Low", since 2015
PubMed studies
0
Mentioning "Eko Low"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Eko Low Ejection Fraction Tool (ELEFT)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Eko Low Ejection Fraction Tool (ELEFT)Breakthrough510(k)
K233409 · Decided Mar 28, 2024 · 174 days after receipt
Device type: Reduced Ejection Fraction Machine Learning-Based Notification Software (QYE) · Cardiology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Eko Low", any status and sponsor, newest update first.
Eko Devices, Inc.Not on our public-company list
NCT07270692 · 500 participants (planned) · Start Aug 1, 2025 · Primary completion Oct 2027
Device: Eko digital stethoscopes · For: Low Ejection Fraction
Sites: Mumbai, India
Eko Devices, Inc.Not on our public-company list
NCT07087613 · 3,850 participants (planned) · Start Jun 15, 2025 · Primary completion May 31, 2027
Device: Eko CORE 500 Digital Stethoscope · For: Hypertension, Pulmonary; Heart Failure With Reduced Ejection Fraction
Sites: O'Fallon, Illinois; Springfield, Illinois; Norfolk, Virginia · 4 sites in all
- Peripheral Systemic Thrombolysis Versus Catheter Directed Thrombolysis for Submassive PEStatus unknown
Northwell HealthAcademic, hospital or other
NCT03581877 · 31 participants · Start Jan 28, 2019 · Primary completion Mar 19, 2023
Device: EKOS · For: Pulmonary Embolism; Pulmonary Hypertension; Thromboembolism and 1 more
Sites: Bay Shore, New York; Queens, New York
2 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Eko Low", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code QYE
0 reports: 0 malfunction, 0 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Eko Low"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code QYE.
- ECG Analysis Software (AiTiALVSD)Medical AI Co., Ltd. · 510(k) 2026
- Bunkerhill ECG-EFBunkerHill Health · 510(k) 2025
- ECG-AI Low Ejection Fraction (LEF) 12-Lead algorithm (1010)Anumana, Inc. · 510(k) 2025
- Tempus ECG-Low EFTempus AI, Inc. · 510(k) 2025
- Low Ejection Fraction AI-ECG AlgorithmAnumana, Inc. · 510(k) 2023
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.